000 | 00964 a2200277 4500 | ||
---|---|---|---|
005 | 20250517030500.0 | ||
264 | 0 | _c20150630 | |
008 | 201506s 0 0 eng d | ||
022 | _a1939-327X | ||
024 | 7 |
_a10.2337/db14-1871 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDeMarco, Vincent G | |
245 | 0 | 0 |
_aGhrelin: a new incretin enhancer therapy? _h[electronic resource] |
260 |
_bDiabetes _cMay 2015 |
||
300 |
_a1500-2 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Comment | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aGhrelin _xpharmacology |
650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aReceptors, Glucagon _xmetabolism |
700 | 1 | _aSowers, James R | |
773 | 0 |
_tDiabetes _gvol. 64 _gno. 5 _gp. 1500-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2337/db14-1871 _zAvailable from publisher's website |
999 |
_c24838309 _d24838309 |